Varex Imaging (VREX) Expected to Announce Quarterly Earnings on Thursday

Varex Imaging (NASDAQ:VREX - Get Free Report) is expected to be releasing its Q2 2025 earnings data after the market closes on Thursday, May 8th. Analysts expect Varex Imaging to post earnings of $0.14 per share and revenue of $206.76 million for the quarter. Varex Imaging has set its Q2 2025 guidance at 0.050-0.200 EPS.

Varex Imaging (NASDAQ:VREX - Get Free Report) last posted its quarterly earnings data on Thursday, February 6th. The company reported $0.07 EPS for the quarter, topping analysts' consensus estimates of $0.04 by $0.03. Varex Imaging had a positive return on equity of 4.00% and a negative net margin of 5.79%. On average, analysts expect Varex Imaging to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Varex Imaging Price Performance

Varex Imaging stock traded down $0.09 on Tuesday, reaching $8.41. The company's stock had a trading volume of 241,579 shares, compared to its average volume of 573,785. The company has a debt-to-equity ratio of 1.02, a quick ratio of 2.50 and a current ratio of 4.36. The company has a market cap of $346.49 million, a price-to-earnings ratio of -7.19 and a beta of 0.65. The business's fifty day moving average price is $10.61 and its 200 day moving average price is $12.93. Varex Imaging has a twelve month low of $6.97 and a twelve month high of $17.02.

Insider Activity

In other news, SVP Kimberley E. Honeysett sold 4,007 shares of the company's stock in a transaction on Thursday, March 20th. The stock was sold at an average price of $12.81, for a total transaction of $51,329.67. Following the transaction, the senior vice president now owns 4,002 shares of the company's stock, valued at $51,265.62. This represents a 50.03 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Sunny Sanyal sold 8,749 shares of the company's stock in a transaction on Wednesday, April 2nd. The shares were sold at an average price of $11.24, for a total value of $98,338.76. Following the transaction, the chief executive officer now directly owns 190,193 shares in the company, valued at $2,137,769.32. This trade represents a 4.40 % decrease in their position. The disclosure for this sale can be found here. 4.30% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of research firms have commented on VREX. Oppenheimer reduced their price objective on Varex Imaging from $30.00 to $23.00 and set an "outperform" rating on the stock in a research note on Friday, February 7th. B. Riley reaffirmed a "buy" rating and set a $22.00 price target (up previously from $21.00) on shares of Varex Imaging in a research note on Friday, February 7th. Finally, StockNews.com raised Varex Imaging from a "hold" rating to a "buy" rating in a research note on Friday, February 7th.

About Varex Imaging

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.